A popular Bitcoin price prediction system, Stock to flow, is not left out amongst the prophets predicting the asset value. NASDAQ 0.00%. Prolung Inc. I n recent trading, shares of Pulmonx Corp (Symbol: LUNG) have crossed above the average analyst 12-month target price of … Vote “Underperform” if you believe LUNG will underperform the S&P 500 over the long term. The chart below shows how a company's share price and consensus price target have changed over time. Find the latest Pulmonx Corporation (LUNG) stock quote, history, news and other vital information to help you with your stock trading and investing. Download 31,795 Lung Stock Illustrations, Vectors & Clipart for FREE or amazingly low rates! ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology, early stage lung cancer risk testing. LUNG Stock Price Chart Interactive Chart > LUNG Price/Volume Stats. lung stock pictures, royalty-free photos & images LUNG: Get the latest Pulmonx stock price and detailed information including LUNG news, historical charts and realtime prices. Pulmonx employs 180 workers across the globe. In depth view into LUNG (Pulmonx) stock including the latest price, news, dividend history, earnings information and financials. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Pulmonx (NASDAQ:LUNG) posted its earnings results on Monday. LUNG Prolung Inc. — Stock Price and Discussion | Stocktwits. Compare Top Brokerages Here. View our full suite of financial calendars and market data tables, all for free. Pulmonx's lock-up period expired on Tuesday, March 30th. LUNG Stock Price Chart Interactive Chart > LUNG Price/Volume Stats. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. LUNG, Pulmonx Corporation - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines The company reported ($0.27) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.28) by $0.01. Filter … DOW 0.00%. (NASDAQ: LUNG) Pulmonx Corp stock price per share is $61.64 today (as of Mar 11, 2021). Nasdaq 100. Let 10 time trading champion Chuck Hughes show you how to start making more income. LUNG Price Target Upside: 19.54% upside: 14.36% upside: 14.62% upside: N/A: Pulmonx (NASDAQ:LUNG) Consensus Price Target History . Latest Stock Picks Investing Basics Premium Services. 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pulmonx in the last year. Pulmonx stock traded down $0.54 during trading hours on Wednesday, reaching $57.51. 158,514,780 stock photos online. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Vote “Outperform” if you believe LUNG will outperform the S&P 500 over the long term. © American Consumer News, LLC dba MarketBeat® 2010-2021. LUNG | Stock Snapshot - Fidelity. Sign Up. Currently, 5.1% of the company's shares are short sold. The average Pulmonx Corp stock price prediction forecasts a potential downside of 13.17% from the current LUNG share price of $61.96. You can opt out at any time. What is the 52 week high and low for Pulmonx Corp (NASDAQ: LUNG)? 07:12 AM ET Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The business had revenue of $9.83 million for the quarter, compared to analyst estimates of $8.70 million. Since Amgen's such a large company, don't be surprised if solid results for AMG 510 have a larger effect on Mirati's stock price than Amgen's. Pulmonx prices IPO at $19 a share, above proposed price range. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. Rooms Shows Rankings Earnings Calendar Shop. Discover historical prices for LUNG stock on Yahoo Finance. Lung Virus Infection Lung virus infection and coronavirus outbreak or viral pneumonia and coronaviruses influenza as a dangerous flu strain cases as a pandemic medical health risk concept with disease cells with 3D render elements. Current price $58.15 : 52-week high $69.48 : Prev. LUNG stock quote, chart and news. Looking for new stock ideas? Stock Price: $47.96 USD-1.04 (-2.12%) Updated Mar 26, 2021 4:00 PM EDT - Market closed. The business has a fifty day moving average of $57.46. 13, 2015 at 7:34 a.m. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View Pulmonx's Short Interest. At the end of the last trading period, MediciNova closed at $5.68. Is It Profit-Taking Time on Avis Budget Group Stock? Pulmonx stock price target raised to $65 from $50 at Stifel Nicolaus MarketWatch. Monthly Subscription. While there is no congruence in the price predictions being made by each expert, one unifying view we can safely deduce is that the coin’s value would rise as time goes by. View the real-time LUNG price chart on Robinhood and decide if you want to buy or sell commission-free. It develops, tests and commercializes solutions which are designed to accelerate the time to diagnosis and expand the therapeutic window for lung … LUNG from the largest community of traders and investors. $52.04. Learn more. With a 5-year investment, the revenue is expected to be around +347.59%. Print. Wall Street analysts have given Pulmonx a "Buy" rating, but there may be better short-term opportunities in the market. View all of LUNG's competitors. Free trial . Please log in to your account or sign up in order to add this asset to your watchlist. View Pulmonx Corporation LUNG investment & stock information. View our earnings forecast for Pulmonx. View analyst ratings for Pulmonx or view top-rated stocks. Pulmonx has a market capitalization of $1.58 billion and generates $32.60 million in revenue each year. Free forex prices, toplists, indices and lots more. free real time technical chart, provides HSI, SSE, Hong Kong stocks, A shares, SMA, Bollinger, Volume, turnover, RSI, MACD Pulmonx (Pulmonx: LUNG) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. Pulmonx does not have a long track record of dividend growth. View Pulmonx Corporation LUNG investment & stock information. MarketBeat's community ratings are surveys of what our community members think about Pulmonx and other stocks. Average Share Price and Price Target by Month. According to the system, BTC price would reach $100,000 this year. PULMONX CORPORATION : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share PULMONX CORPORATION | Nasdaq: LUNG | Nasdaq Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. View LUNG's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Do Not Sell My Information. Lung Videos - Download 3,173 stock videos with Lung for FREE or amazingly low rates! Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Pulmonx is scheduled to release its next quarterly earnings announcement on Tuesday, June 1st 2021. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Their average twelve-month price target is $57.33, predicting that the stock has a possible upside of 19.54%. -2.45 (-4.43%) CLOSED AT 4:00 PM ET ON Mar 19, 2021. 09:51 AM ET. Based on our forecasts, a long-term increase is expected, the "LUNG" stock price prognosis for 2026-03-20 is 214.843 USD. S&P 500 3,904.00 (+0.38%) ET by Tomi Kilgore Danaher to buy Pall Corp. in a deal valued at $13.8 bln Pulmonx updated its FY 2021 Pulmonx (LUNG) stock price, charts, trades & the US's most popular discussion forums. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted. Monthly Subscription. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Big Cap Pro. There are currently 3 hold ratings and 3 buy ratings for the stock. 6 Wall Street analysts have issued ratings and price targets for Pulmonx in the last 12 months. Stock analysis for Hang Lung Properties Ltd (101:Hong Kong) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Receive a free world-class investing education from MarketBeat. Pulmonx saw a decline in short interest in the month of February. Sign-up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Find market predictions, LUNG financials and market news. Pulmonx has received a consensus rating of Buy. These industry giants could make big moves after this year's World Conference on Lung Cancer. View live PULMONX CORPORATION chart to track its stock's price action. Pulmonx started at equal weight at Morgan Stanley MarketWatch. The company provided earnings per share guidance of for the period. What is Pulmonx Corp's Market Cap? The stock has a 52-week-high of $13.25 and a 52-week-low of $2.79. As of February 12th, there was short interest totaling 921,700 shares, a decline of 32.2% from the January 28th total of 1,360,000 shares. You can change your choices at any time by visiting Your Privacy Controls. Pulmonx has only been the subject of 4 research reports in the past 90 days. LUNG Pulmonx Stock Price . Shares of LUNG can be purchased through any online brokerage account. Data is currently not available. Current price $58.15 : 52-week high $69.48 : Prev. The stock presently has a consensus rating of "Hold" and an average price target of $57.33. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. Watch. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Monday, October 26, 2020. Pulmonx had issued 10,000,000 shares in its IPO on October 1st. Find market predictions, 101 financials and market news. (LUNG) raised $100 million in an initial public offering (IPO) on Thursday, October 1st 2020. Company Profile. Discover historical prices for LUNG stock on Yahoo Finance. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. MarketBeat just released five new trading ideas, but Pulmonx wasn't one of them. One share of LUNG stock can currently be purchased for approximately $44.35. Top institutional investors include BlackRock Inc. (2.38%), Primecap Management Co. CA (2.05%), Pura Vida Investments LLC (1.10%), Janus Henderson Group PLC (1.05%), Price T Rowe Associates Inc. MD (1.04%) and PFM Health Sciences LP (0.85%). 4 Upgrades In Big Tech Moving The Markets Now, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, Pulmonx (NASDAQ:LUNG) Shares Gap Down to $44.32, Pulmonx (NASDAQ:LUNG) Stock Price Down 7.5%, Pulmonx (NASDAQ:LUNG) Receives New Coverage from Analysts at Piper Sandler, Pulmonx Co. (NASDAQ:LUNG) Given Average Rating of "Hold" by Analysts, Pulmonx (NASDAQ:LUNG) Upgraded by Bank of America to "Buy", Tandem Diabetes Care (NASDAQ:TNDM) & Pulmonx (NASDAQ:LUNG) Head-To-Head Contrast, LUNG Crosses Above Average Analyst Target, Pulmonx (NASDAQ:LUNG) Upgraded to "Buy" by Bank of America, Morgan Stanley Boosts Pulmonx (NASDAQ:LUNG) Price Target to $53.00, Pulmonx (NASDAQ:LUNG) Price Target Raised to $65.00, Pulmonx (NASDAQ:LUNG) Shares Up 11.5% Following Analyst Upgrade, Here's What Pulmonx Corporation's (NASDAQ:LUNG) Shareholder Ownership Structure Looks Like, Pulmonx Corporation (LUNG) Q4 2020 Earnings Call Transcript, Pulmonx Reports Fourth Quarter and Full Year 2020 Financial Results, Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021, Diaphragm Pacing Therapy System Market Potential Growth, Share, Demand, Analysis of Key Players and Forecasts to 2020-2027, Radiological Analysis Leveraging Artificial Intelligence Is Moving Past Pure Identification Of Tumors, JTV®, Pulmonx® Corporation & Respiratory Health Association® Launch 2021 Catch Your Breath® Campaign. View Pulmonx's earnings history. View which stocks are hot on social media with MarketBeat's trending stocks report. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 13, 2015 at 7:33 a.m. View today's stock price, news and analysis for Pulmonx Corp. (LUNG). Stock … The company can be reached via phone at 650-364-0400 or via email at [email protected]. The company reported ($0.27) EPS for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.01, MarketWatch Earnings reports. Real-time trade and investing ideas on Prolung Inc. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Pulmonx (Pulmonx: LUNG) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. Pulmonx has a 52 week low of $37.64 and a 52 week high of $69.48. Get the latest Pulmonx Corporation LUNG detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stock analysis for Lung Yen Life Service Corp (5530:Taipei) including stock price, stock chart, company news, key statistics, fundamentals and company profile. PRIVATE Updated Feb 19, 2021 2:20 PM. Get Pulmonx Corp.'s stock price today. lung $53.74 $0.84 1.6% Price as of March 22, 2021, 3:56 p.m. EDT View Interactive LUNG Charts View the real-time LUNG price chart on Robinhood and decide if you want to buy or sell commission-free. Mar 12, 2021 9:08AM EST. for only. Eli Lilly: LOXO-292 Pulmonx upsizes IPO to 10 mln shares, lifts price range to $17 to $18 vs. prior $14 to $16 Sep. 30, 2020 at 6:21 a.m. According to analysts' consensus price target of $57.33, Pulmonx has a forecasted upside of 30.8% from its current price of $43.83. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings. Pulmonx Corp quote is equal to 48.000 USD at 2021-03-28. LUNG KEE (BERMUDA) HLDGS LTD (L09.SI) Share Price History of Lung Kee Bermuda | SGX Listed Companies @ SG investors.io 6 analysts have issued 12-month price targets for Pulmonx's stock. Learn about financial terms, types of investments, trading strategies and more. view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Their average twelve-month price target is $49.40, suggesting a possible downside of 13.1%. Monday, October 26, 2020. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Pulmonx against related stocks people have also bought. 11:34 AM ET. Stock quote and company snapshot for PULMONX CORP (LUNG), including profile, stock chart, recent news and events, analyst opinions, and research reports. On average, Wall Street analysts predict that Pulmonx Corp's share price could fall to $53.80 by Jan 4, 2022. View today's stock price, news and analysis for Pulmonx Corp. (LUNG). 12,813 shares of the company were exchanged, compared to its average volume of 143,227. Your current $100 investment may be … Our Accessibility Statement Trending now. Image source: Getty Images. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. After-Hours earnings guidance on Tuesday, March, 2nd. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. Pulmonx Co. (NASDAQ:LUNG) announced its quarterly earnings data on Monday, March, 1st. for only. New users enjoy 60% OFF. 09:51 AM ET. Prolung Inc. 58.97 0.61 (1.05%) Watch. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Some companies that are related to Pulmonx include Globus Medical (GMED), Haemonetics (HAE), Integra LifeSciences (IART), Inspire Medical Systems (INSP), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Nevro (NVRO), ICU Medical (ICUI), iRhythm Technologies (IRTC), Glaukos (GKOS), ShockWave Medical (SWAV), Cantel Medical (CMD), NuVasive (NUVA), Merit Medical Systems (MMSI) and AtriCure (ATRC). LUNG Charts (Price in USD) - 2021-03-12 Stock Forecast / Price Prediction / Prognosis: Pulmonx Corp Forecast Predictions, Comments & Questions Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock analysis for Lung Yen Life Service Corp (5530:Taipei) including stock price, stock chart, company news, key statistics, fundamentals and company profile. In depth view into LUNG (Pulmonx) stock including the latest price, news, dividend history, earnings information and financials. LUNG 58.97 0.61 (1.05%) Post-Market 0.00 (0.00%) 130. Want to see which stocks are moving? Pulmonx (LUNG) stock price, charts, trades & the US's most popular discussion forums. The official website for Pulmonx is pulmonx.com. Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive … ET by Tomi Kilgore Danaher's $127.20 a share bid for Pall is 7.2% above to Tuesday's closing price On average, they expect Pulmonx's share price to reach $57.33 in the next twelve months. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Danaher's $127.20 a share bid for Pall is 7.2% above to Tuesday's closing price May. Pall's stock surges 5% premarket after buyout deal with Danaher May. This suggests a possible upside of 29.3% from the stock's current price. LUNG KEE (BERMUDA) HLDGS LTD (L09.SI) Share Price History of Lung Kee Bermuda | SGX Listed Companies @ SG investors.io Pulmonx started at buy with $49 stock price target at Canaccord Genuity MarketWatch. View the latest Pulmonx Corp. (LUNG) stock price, news, historical charts, analyst ratings and financial information from WSJ. 5 Wall Street analysts have set twelve-month price targets for Pulmonx in the last year. Export data to Excel for your own analysis. LUNG 57.62 1.49 (2.66%) ), Pulmonx has received 12 “underperform” votes. Pulmonx started at equal weight at Morgan Stanley MarketWatch. Pulmonx has received 8 “outperform” votes. Based on an average trading volume of 214,600 shares, the days-to-cover ratio is currently 4.3 days. $33.03. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. (NASDAQ: LUNG) Pulmonx Corp's 52-week high was $69.48, and its 52-week low was $37.64. In the past three months, Pulmonx insiders have not sold or bought any company stock. A high-level overview of Pulmonx Corporation (LUNG) stock. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The consensus among Wall Street equities research analysts is that investors should "buy" Pulmonx stock. PULMONX CORPORATION (NASDAQ:LUNG) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PULMONX CORPORATION | Nasdaq: LUNG | Nasdaq S&P 500 0.00%. New users enjoy 60% OFF. 52.90-2.45 (-4.43%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! Stock analysis for Hang Lung Properties Ltd (101:Hong Kong) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Pulmonx has received 60.00% “underperform” votes from our community. Small Cap Basic. You may vote once every thirty days. Morgan Stanley has the highest price target set, predicting LUNG will reach $52.00 in the next twelve months. Identify stocks that meet your criteria using seven unique stock screeners. Pulmonx does not currently pay a dividend. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Pulmonx against related stocks people have also bought. Who Has Been Buying Pulmonx Corporation (NASDAQ:LUNG) Shares? Learn more. Free forex prices, toplists, indices and lots more. Log In. Pulmonx Corporation Common Stock. Pulmonx started at buy with $49 stock price target at Canaccord Genuity MarketWatch. Pulmonx stock price target raised to $65 from $50 at Stifel Nicolaus MarketWatch. 07:12 … $52.90. Learn everything you need to know about successful options trading with this three-part video course. See what's happening in the market right now with MarketBeat's real-time news feed. Pulmonx trades on the NASDAQ under the ticker symbol "LUNG.". 11:34 AM ET. If you’re ready to start capitalizing on this massive boom, legendary crypto investor Matt McCall just released a new free report, “3 Cryptos to Beat Bitcoin.”, Sr. VP & GM of Europe Middle-East & Africa, Start Your Risk-Free Trial Subscription Here, McCormick Stock Is Seasoned Just Right For Value Investors, Houghton Mifflin Harcourt Stock Up 24% Yesterday - Here's Why, Canoo Stock Sinks After No-Revenue Quarter, 3 Telecom Infrastructure Stocks Signaling Big Gains. Real time Pulmonx Corporation (LUNG) stock price quote, stock graph, news & analysis. (NASDAQ: LUNG) Pulmonx Corp's … It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Get the latest Pulmonx Corporation LUNG detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. DJIA: 32,778.64 +293.05 (0.90%) | NASDAQ: 13,319.865 -78.808 (-0.59%) | S&P 500: 3,943.34 +4.00 (0.10%) — Markets closed. Analyzing Pulmonx (NASDAQ:LUNG) stock? $52.90. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Pulmonx's stock is owned by a variety of retail and institutional investors. All rights reserved. Free trial. The dark blue line represents the company's actual price. Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Return. Fundamental company data provided by Zacks Investment Research.